Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Wendy Armstrong

Concepts (371)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
68
2026
3193
5.630
 Why?
Epidemics
7
2026
96
2.220
 Why?
Communicable Diseases
8
2023
166
1.820
 Why?
Anti-Retroviral Agents
5
2019
251
1.630
 Why?
Anti-HIV Agents
14
2026
912
1.540
 Why?
Viral Load
14
2026
526
1.150
 Why?
Infectious Disease Medicine
2
2017
12
1.040
 Why?
Continuity of Patient Care
5
2022
297
0.960
 Why?
AIDS-Related Opportunistic Infections
5
2019
130
0.870
 Why?
HIV
13
2023
251
0.870
 Why?
Internal Medicine
3
2016
279
0.860
 Why?
Social Stigma
2
2024
172
0.820
 Why?
Immune Reconstitution Inflammatory Syndrome
2
2019
20
0.740
 Why?
Internship and Residency
6
2021
1267
0.680
 Why?
Pre-Exposure Prophylaxis
3
2024
269
0.640
 Why?
Drug Monitoring
2
2016
401
0.640
 Why?
Antiretroviral Therapy, Highly Active
6
2019
279
0.620
 Why?
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
2020
19
0.620
 Why?
Adenine
2
2020
339
0.610
 Why?
Diagnostic Tests, Routine
2
2021
107
0.600
 Why?
Acquired Immunodeficiency Syndrome
7
2022
237
0.590
 Why?
Humans
97
2026
145474
0.580
 Why?
Consumer Advocacy
1
2018
12
0.560
 Why?
United States
27
2026
16098
0.540
 Why?
Career Choice
3
2018
234
0.540
 Why?
Lost to Follow-Up
2
2017
20
0.540
 Why?
HIV-1
8
2026
908
0.520
 Why?
Delivery of Health Care
4
2021
946
0.510
 Why?
Health Policy
3
2023
400
0.500
 Why?
Health Services Accessibility
4
2024
1101
0.500
 Why?
CD4 Lymphocyte Count
6
2020
280
0.480
 Why?
Georgia
10
2024
79
0.470
 Why?
Substance-Related Disorders
6
2021
1102
0.470
 Why?
Medication Adherence
2
2017
540
0.460
 Why?
Rilpivirine
2
2026
10
0.450
 Why?
Antimicrobial Stewardship
3
2023
130
0.440
 Why?
Disease Management
1
2019
653
0.440
 Why?
HIV-Associated Lipodystrophy Syndrome
1
2014
9
0.430
 Why?
Urban Population
1
2017
493
0.410
 Why?
Biomedical Research
2
2018
717
0.410
 Why?
Bone Diseases
1
2014
61
0.400
 Why?
Financing, Government
1
2014
53
0.400
 Why?
Metabolic Diseases
1
2014
114
0.380
 Why?
Drug Resistance, Viral
2
2005
126
0.380
 Why?
Patient Acceptance of Health Care
2
2017
881
0.380
 Why?
Rural Population
1
2017
659
0.360
 Why?
Ventriculostomy
1
2012
24
0.360
 Why?
Medication Errors
1
2012
85
0.350
 Why?
Chronic Pain
3
2021
291
0.350
 Why?
Central Nervous System Diseases
1
2012
74
0.340
 Why?
Mycoses
1
2012
88
0.340
 Why?
Ambulatory Care
2
2021
609
0.330
 Why?
Prostheses and Implants
1
2012
137
0.330
 Why?
Disease Transmission, Infectious
1
2011
69
0.320
 Why?
Gram-Positive Bacterial Infections
2
2008
71
0.320
 Why?
Critical Care
1
2016
702
0.310
 Why?
Cellulitis
2
2011
54
0.310
 Why?
Microbiology
3
2014
24
0.310
 Why?
Bacterial Infections
1
2012
246
0.300
 Why?
Physicians
5
2019
955
0.300
 Why?
Analgesics, Opioid
5
2021
1149
0.300
 Why?
Dermatitis
1
2008
20
0.290
 Why?
Medical Informatics
1
2009
99
0.280
 Why?
Patient-Centered Care
1
2014
547
0.280
 Why?
Male
41
2026
72842
0.280
 Why?
Female
42
2026
78844
0.280
 Why?
Global Health
2
2018
403
0.280
 Why?
Gram-Negative Bacterial Infections
1
2008
49
0.280
 Why?
Adult
33
2026
40777
0.270
 Why?
Education, Medical, Graduate
5
2023
562
0.260
 Why?
Africa, Eastern
2
2017
12
0.260
 Why?
Middle Aged
32
2026
36215
0.260
 Why?
Information Dissemination
1
2009
224
0.260
 Why?
Delayed Diagnosis
2
2026
100
0.260
 Why?
AIDS Vaccines
2
2005
53
0.260
 Why?
Periodicals as Topic
1
2009
209
0.250
 Why?
Viremia
2
2026
160
0.240
 Why?
Pneumonia, Pneumocystis
4
2015
34
0.240
 Why?
Developing Countries
3
2017
316
0.240
 Why?
Pyridones
2
2026
209
0.230
 Why?
Mycobacterium chelonae
1
2005
8
0.230
 Why?
Internet
2
2014
689
0.230
 Why?
Curriculum
5
2023
1070
0.230
 Why?
Databases, Factual
2
2019
1490
0.220
 Why?
Exosomes
2
2016
104
0.210
 Why?
Skin
1
2008
753
0.200
 Why?
Meningoencephalitis
1
2003
24
0.190
 Why?
Fellowships and Scholarships
4
2023
354
0.190
 Why?
Cost-Benefit Analysis
3
2021
639
0.190
 Why?
West Nile virus
1
2003
41
0.190
 Why?
Bacteria
1
2008
765
0.190
 Why?
Practice Guidelines as Topic
3
2019
1581
0.180
 Why?
Interviews as Topic
2
2017
910
0.180
 Why?
Anti-Infective Agents
3
2015
232
0.180
 Why?
Pain Management
3
2021
410
0.180
 Why?
Simulation Training
1
2023
135
0.170
 Why?
Colony-Stimulating Factors
1
2001
37
0.170
 Why?
Coronary Artery Bypass
1
2003
268
0.170
 Why?
Pandemics
4
2026
1707
0.170
 Why?
Erythrocyte Transfusion
1
2003
225
0.170
 Why?
Mycobacterium Infections, Nontuberculous
1
2005
339
0.160
 Why?
Contact Tracing
1
2020
26
0.160
 Why?
Obesity
1
2014
3116
0.160
 Why?
Prescription Drug Misuse
1
2021
52
0.160
 Why?
Cities
4
2022
138
0.160
 Why?
Mass Screening
2
2020
1360
0.160
 Why?
Models, Theoretical
2
2021
558
0.160
 Why?
Erythropoietin
1
2001
100
0.150
 Why?
Registries
2
2019
2406
0.150
 Why?
Sexual and Gender Minorities
1
2024
259
0.150
 Why?
Antibodies, Monoclonal, Humanized
1
2026
992
0.150
 Why?
Policy
1
2021
148
0.150
 Why?
Life Expectancy
1
2020
73
0.150
 Why?
Interleukin-2
1
2001
440
0.150
 Why?
Heart Diseases
1
2022
341
0.150
 Why?
Alanine
1
2020
169
0.140
 Why?
Fever of Unknown Origin
1
1999
13
0.140
 Why?
Leukoencephalopathy, Progressive Multifocal
1
2019
38
0.140
 Why?
Cross-Sectional Studies
5
2021
5904
0.140
 Why?
Cohort Studies
7
2019
6013
0.140
 Why?
Health Equity
1
2021
133
0.140
 Why?
Mentors
2
2018
217
0.140
 Why?
Comorbidity
2
2020
1661
0.140
 Why?
Prevalence
5
2024
2865
0.140
 Why?
Microbial Sensitivity Tests
3
2016
364
0.140
 Why?
Tenofovir
1
2020
301
0.130
 Why?
Sexually Transmitted Diseases
1
2020
168
0.130
 Why?
Physician Assistants
1
2019
101
0.130
 Why?
Capital Financing
1
2017
7
0.130
 Why?
Patient Identification Systems
1
2017
16
0.130
 Why?
Sustained Virologic Response
1
2017
46
0.130
 Why?
Nurse Practitioners
1
2019
138
0.130
 Why?
Africa
1
2017
119
0.130
 Why?
Risk Factors
7
2020
10885
0.130
 Why?
Hospitalization
4
2020
2460
0.130
 Why?
Anti-Bacterial Agents
4
2011
1923
0.120
 Why?
Financing, Personal
1
2016
27
0.120
 Why?
Research Personnel
1
2018
184
0.120
 Why?
Viral Tropism
1
2016
36
0.120
 Why?
Case Management
1
2016
68
0.120
 Why?
Motivation
2
2017
600
0.110
 Why?
Hospitals
2
2021
732
0.110
 Why?
Diketopiperazines
2
2026
23
0.110
 Why?
Opioid-Related Disorders
2
2021
602
0.110
 Why?
Pneumonia, Viral
1
2020
389
0.110
 Why?
Coronavirus Infections
1
2020
383
0.110
 Why?
Drug Utilization Review
1
2015
61
0.110
 Why?
Organizational Policy
1
2015
78
0.110
 Why?
HIV Protease Inhibitors
1
2015
69
0.110
 Why?
Online Systems
1
2014
20
0.110
 Why?
Esophageal Diseases
1
2015
30
0.110
 Why?
Candidiasis
1
2015
64
0.110
 Why?
Cytosol
1
2015
213
0.110
 Why?
Time-to-Treatment
1
2017
251
0.110
 Why?
Pregnancy Complications, Infectious
1
2019
440
0.100
 Why?
Patient Navigation
1
2016
126
0.100
 Why?
Alcoholism
1
2021
822
0.100
 Why?
Retrospective Studies
8
2026
17291
0.100
 Why?
Organophosphates
1
2015
179
0.100
 Why?
Drug Interactions
1
2015
405
0.100
 Why?
Healthcare Disparities
1
2020
735
0.100
 Why?
Ambulatory Care Facilities
1
2016
269
0.100
 Why?
Patient Readmission
1
2019
769
0.100
 Why?
DNA, Viral
2
2012
356
0.090
 Why?
Health Plan Implementation
1
2014
141
0.090
 Why?
Dihydropteroate Synthase
2
2004
3
0.090
 Why?
Medication Reconciliation
1
2012
32
0.090
 Why?
Leukocytes, Mononuclear
1
2015
574
0.090
 Why?
Incidence
2
2021
2923
0.090
 Why?
Oligopeptides
1
2014
267
0.090
 Why?
Telemedicine
1
2021
961
0.090
 Why?
Pilot Projects
2
2017
1891
0.090
 Why?
HIV Antibodies
1
2012
61
0.090
 Why?
Myocardial Infarction
2
2019
1210
0.090
 Why?
Longitudinal Studies
2
2019
2953
0.090
 Why?
Socioeconomic Factors
2
2020
1323
0.090
 Why?
Mycobacterium haemophilum
1
2011
1
0.090
 Why?
Primary Health Care
2
2019
1735
0.090
 Why?
Aged
8
2022
26153
0.090
 Why?
Parasitic Diseases
1
2011
8
0.080
 Why?
Research
1
2014
430
0.080
 Why?
Mycobacterium Infections
1
2011
55
0.080
 Why?
Cytomegalovirus
1
2012
168
0.080
 Why?
Pneumocystis
2
2001
8
0.080
 Why?
Catheter-Related Infections
1
2012
96
0.080
 Why?
Simian Immunodeficiency Virus
1
2011
93
0.080
 Why?
Electronic Health Records
1
2019
1196
0.080
 Why?
Simian Acquired Immunodeficiency Syndrome
1
2011
92
0.080
 Why?
Health Care Costs
1
2014
425
0.080
 Why?
Geography
1
2011
187
0.080
 Why?
Cytokines
2
2016
2067
0.080
 Why?
Education, Medical, Undergraduate
1
2013
207
0.080
 Why?
Surveys and Questionnaires
5
2023
6066
0.080
 Why?
Cytomegalovirus Infections
1
2012
206
0.080
 Why?
Sulfonamides
1
2014
583
0.080
 Why?
Rectum
1
2011
182
0.080
 Why?
Pyridines
1
2014
609
0.080
 Why?
Antibodies, Neutralizing
1
2012
340
0.070
 Why?
Adolescent
5
2021
22529
0.070
 Why?
Desiccation
1
2009
26
0.070
 Why?
Deep Brain Stimulation
1
2012
219
0.070
 Why?
Drug Therapy, Combination
3
2014
1044
0.070
 Why?
Colon
1
2011
309
0.070
 Why?
Education, Medical, Continuing
1
2009
133
0.070
 Why?
Emigrants and Immigrants
1
2011
157
0.070
 Why?
Syphilis, Cutaneous
1
2007
3
0.070
 Why?
Immunoglobulin G
1
2012
892
0.070
 Why?
Dendritic Cells
1
2011
499
0.070
 Why?
Specimen Handling
1
2009
182
0.060
 Why?
Hepacivirus
1
2009
242
0.060
 Why?
Plasma
1
2009
223
0.060
 Why?
B-Lymphocytes
1
2012
870
0.060
 Why?
Risk Assessment
3
2019
3747
0.060
 Why?
Treatment Outcome
6
2024
11772
0.060
 Why?
Young Adult
3
2021
14218
0.060
 Why?
Hepatitis C
1
2009
256
0.060
 Why?
Acetamides
1
2026
41
0.060
 Why?
Indazoles
1
2026
85
0.060
 Why?
HIV-2
1
2005
18
0.050
 Why?
Diagnosis, Differential
2
2007
1508
0.050
 Why?
Dapsone
2
2004
8
0.050
 Why?
Sex Factors
1
2011
2105
0.050
 Why?
CD4-Positive T-Lymphocytes
1
2011
1140
0.050
 Why?
Trimethoprim, Sulfamethoxazole Drug Combination
2
2004
43
0.050
 Why?
Patient Education as Topic
1
2009
777
0.050
 Why?
Pneumocystis carinii
1
2004
12
0.050
 Why?
Chronic Disease
2
2012
1808
0.050
 Why?
Mediastinitis
1
2003
3
0.050
 Why?
Virulence
1
2005
278
0.050
 Why?
Vancomycin Resistance
1
2003
16
0.050
 Why?
Enterococcus faecium
1
2003
22
0.050
 Why?
Delayed-Action Preparations
1
2024
189
0.050
 Why?
Wound Healing
1
2005
355
0.050
 Why?
Fatal Outcome
1
2003
305
0.050
 Why?
Liver Failure
1
2002
83
0.040
 Why?
Biopsy
1
2005
1082
0.040
 Why?
Cryptococcosis
1
2001
31
0.040
 Why?
Transplantation, Homologous
1
2002
418
0.040
 Why?
Dental Care
1
2021
25
0.040
 Why?
Intracranial Hypertension
1
2001
42
0.040
 Why?
Coronary Disease
2
2003
381
0.040
 Why?
Blood
2
2012
107
0.040
 Why?
Naphthoquinones
1
2001
20
0.040
 Why?
Cytochrome b Group
1
2001
22
0.040
 Why?
Quality-Adjusted Life Years
1
2021
123
0.040
 Why?
Mutation
2
2004
4075
0.040
 Why?
Adipose Tissue
1
2005
645
0.040
 Why?
Time Factors
3
2019
7123
0.040
 Why?
Patient Outcome Assessment
1
2021
130
0.040
 Why?
Meningitis
1
2001
80
0.040
 Why?
Renal Insufficiency
1
2002
172
0.040
 Why?
Neutropenia
1
2001
154
0.040
 Why?
Antifungal Agents
1
2001
151
0.040
 Why?
Trust
1
2021
155
0.040
 Why?
Prospective Studies
1
2012
8057
0.040
 Why?
Personal Satisfaction
1
2021
219
0.040
 Why?
Anemia
1
2001
191
0.040
 Why?
JC Virus
1
2019
23
0.040
 Why?
Spinal Diseases
1
1999
50
0.040
 Why?
Polyomavirus Infections
1
2019
30
0.040
 Why?
Boston
1
2019
93
0.040
 Why?
Antiviral Agents
1
2005
769
0.040
 Why?
Asymptomatic Infections
1
2019
37
0.040
 Why?
Abscess
1
1999
77
0.040
 Why?
Polymerase Chain Reaction
3
2011
1041
0.040
 Why?
Esophageal Stenosis
1
1999
60
0.040
 Why?
Antibodies, Monoclonal
1
2026
1505
0.040
 Why?
Training Support
1
2018
35
0.030
 Why?
Insurance, Health
1
2021
310
0.030
 Why?
Benchmarking
1
2019
191
0.030
 Why?
Preceptorship
1
2018
63
0.030
 Why?
Health Status Disparities
1
2021
321
0.030
 Why?
Recombinant Proteins
1
2001
1368
0.030
 Why?
Heart-Assist Devices
1
2003
568
0.030
 Why?
Substance Abuse Detection
1
2019
110
0.030
 Why?
Dyslipidemias
1
2019
184
0.030
 Why?
Multicenter Studies as Topic
1
2019
412
0.030
 Why?
Patient Satisfaction
1
2021
709
0.030
 Why?
Hospitals, Public
1
2017
30
0.030
 Why?
Drug Administration Schedule
1
2019
782
0.030
 Why?
Prenatal Care
1
2019
309
0.030
 Why?
Odds Ratio
1
2019
1082
0.030
 Why?
Medicare
1
2022
903
0.030
 Why?
Ultracentrifugation
1
2016
50
0.030
 Why?
Postpartum Period
1
2019
373
0.030
 Why?
Public Health Surveillance
1
2016
83
0.030
 Why?
Needs Assessment
1
2018
402
0.030
 Why?
Multivariate Analysis
1
2019
1547
0.030
 Why?
Virion
1
2016
108
0.030
 Why?
Stents
1
1999
564
0.030
 Why?
Motivational Interviewing
1
2016
121
0.030
 Why?
Guideline Adherence
1
2019
586
0.030
 Why?
Neopterin
1
2014
13
0.030
 Why?
Darunavir
1
2014
20
0.030
 Why?
Atazanavir Sulfate
1
2014
42
0.030
 Why?
Societies, Medical
1
2018
899
0.030
 Why?
Ritonavir
1
2014
75
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2016
848
0.020
 Why?
Antigens, CD
1
2016
558
0.020
 Why?
Randomized Controlled Trials as Topic
1
2019
1747
0.020
 Why?
Biomarkers
2
2016
4295
0.020
 Why?
Blood Proteins
1
2014
239
0.020
 Why?
Qualitative Research
1
2020
1674
0.020
 Why?
Transplantation
1
2012
33
0.020
 Why?
Smoking
1
2019
1472
0.020
 Why?
Inpatients
1
2016
553
0.020
 Why?
Rifabutin
1
2011
7
0.020
 Why?
Clarithromycin
1
2011
24
0.020
 Why?
Ofloxacin
1
2011
17
0.020
 Why?
Receptors, Immunologic
1
2012
208
0.020
 Why?
Integrins
1
2011
90
0.020
 Why?
Macaca mulatta
1
2011
186
0.020
 Why?
Hypertension
1
2019
1273
0.020
 Why?
Quality of Life
1
2023
3204
0.020
 Why?
Data Interpretation, Statistical
1
2012
368
0.020
 Why?
Programmed Cell Death 1 Receptor
1
2012
265
0.020
 Why?
RNA, Viral
1
2014
692
0.020
 Why?
Practice Patterns, Physicians'
1
2019
1371
0.020
 Why?
Immunocompromised Host
1
2011
202
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2011
749
0.020
 Why?
Blotting, Western
1
2011
1179
0.020
 Why?
Health Promotion
1
2015
775
0.020
 Why?
Cells, Cultured
1
2016
4148
0.020
 Why?
False Negative Reactions
1
2007
61
0.020
 Why?
Feces
1
2011
495
0.020
 Why?
Protein Binding
1
2014
2238
0.020
 Why?
Flow Cytometry
1
2011
1162
0.020
 Why?
Lymphocyte Activation
1
2011
1132
0.020
 Why?
Neoplasms
1
2002
2906
0.020
 Why?
Cardiovascular Diseases
1
2019
2187
0.020
 Why?
Pregnancy
1
2019
7202
0.010
 Why?
Gene Expression Profiling
1
2011
1767
0.010
 Why?
Genotype
1
2009
1852
0.010
 Why?
T-Lymphocytes
1
2012
1996
0.010
 Why?
Chemoprevention
1
2004
92
0.010
 Why?
China
1
2004
270
0.010
 Why?
Infant
1
2016
10077
0.010
 Why?
Atovaquone
1
2001
4
0.010
 Why?
Survival
1
2001
38
0.010
 Why?
Child, Preschool
1
2016
11853
0.010
 Why?
Ubiquinone
1
2001
35
0.010
 Why?
Reproducibility of Results
1
2009
3413
0.010
 Why?
Gene Amplification
1
2001
118
0.010
 Why?
Cardiomyopathy, Dilated
1
2003
356
0.010
 Why?
Sulfones
1
2000
127
0.010
 Why?
Epidural Space
1
1999
17
0.010
 Why?
Postoperative Complications
2
2003
2970
0.010
 Why?
Radiotherapy, Adjuvant
1
1999
222
0.010
 Why?
Animals
2
2011
38030
0.010
 Why?
Recurrence
1
2001
1138
0.010
 Why?
Polymorphism, Genetic
1
2001
614
0.010
 Why?
Radiation Injuries
1
1999
149
0.010
 Why?
Esophagus
1
1999
262
0.010
 Why?
Heart Transplantation
1
2003
680
0.010
 Why?
Molecular Sequence Data
1
2001
2883
0.010
 Why?
Child
1
2016
22707
0.010
 Why?
Esophageal Neoplasms
1
1999
348
0.010
 Why?
Carcinoma, Squamous Cell
1
1999
641
0.010
 Why?
Follow-Up Studies
1
2003
5423
0.010
 Why?
Case-Control Studies
1
2001
3623
0.010
 Why?
Angina Pectoris
1
1971
76
0.010
 Why?
Coronary Vessels
1
1971
246
0.000
 Why?
Tomography, X-Ray Computed
1
1999
2769
0.000
 Why?
Aorta
1
1971
440
0.000
 Why?
Magnetic Resonance Imaging
1
1999
3904
0.000
 Why?
Angiocardiography
1
1971
1
0.000
 Why?
Methods
1
1971
68
0.000
 Why?
Extracorporeal Circulation
1
1971
14
0.000
 Why?
Saphenous Vein
1
1971
37
0.000
 Why?
Transplantation, Autologous
1
1971
300
0.000
 Why?
Emergencies
1
1971
174
0.000
 Why?
Armstrong's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (371) concept(s)
_
Co-Authors Expand Description
See all (10) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)